EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,149,524 | -16.0% | 643,597 | +3.5% | 0.00% | – |
| Q2 2023 | $12,085,576 | -43.7% | 621,686 | -17.8% | 0.00% | -100.0% |
| Q1 2023 | $21,468,487 | -3.8% | 756,732 | -0.9% | 0.00% | 0.0% |
| Q4 2022 | $22,326,079 | +9.0% | 763,807 | -1.5% | 0.00% | 0.0% |
| Q3 2022 | $20,488,000 | -40.2% | 775,515 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $34,288,000 | -11.3% | 771,759 | -1.2% | 0.00% | 0.0% |
| Q1 2022 | $38,644,000 | -0.2% | 780,851 | +2.7% | 0.00% | 0.0% |
| Q4 2021 | $38,724,000 | -9.0% | 760,468 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $42,564,000 | +32.0% | 763,066 | +1.3% | 0.00% | 0.0% |
| Q2 2021 | $32,240,000 | -0.1% | 753,280 | -2.6% | 0.00% | 0.0% |
| Q1 2021 | $32,267,000 | -9.4% | 773,067 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $35,622,000 | +13.5% | 764,935 | +3.5% | 0.00% | 0.0% |
| Q3 2020 | $31,389,000 | -10.7% | 738,909 | +0.8% | 0.00% | 0.0% |
| Q2 2020 | $35,167,000 | +3.3% | 732,944 | -0.9% | 0.00% | 0.0% |
| Q1 2020 | $34,032,000 | -25.5% | 739,802 | -2.7% | 0.00% | -50.0% |
| Q4 2019 | $45,683,000 | +6.2% | 760,370 | +0.0% | 0.00% | 0.0% |
| Q3 2019 | $42,999,000 | +2.5% | 760,103 | +0.9% | 0.00% | 0.0% |
| Q2 2019 | $41,952,000 | +10.0% | 753,474 | -0.3% | 0.00% | +100.0% |
| Q1 2019 | $38,150,000 | +30.0% | 755,573 | +3.7% | 0.00% | 0.0% |
| Q4 2018 | $29,348,000 | -37.3% | 728,409 | +7.9% | 0.00% | -50.0% |
| Q3 2018 | $46,794,000 | +0.5% | 674,951 | +9.7% | 0.00% | 0.0% |
| Q2 2018 | $46,567,000 | +52.6% | 615,477 | +6.2% | 0.00% | +100.0% |
| Q1 2018 | $30,521,000 | +0.3% | 579,280 | +1.7% | 0.00% | 0.0% |
| Q4 2017 | $30,438,000 | -9.8% | 569,794 | +0.7% | 0.00% | -50.0% |
| Q3 2017 | $33,755,000 | -23.8% | 565,975 | +0.7% | 0.00% | 0.0% |
| Q2 2017 | $44,322,000 | +16.7% | 561,820 | +22.7% | 0.00% | 0.0% |
| Q1 2017 | $37,991,000 | +11.7% | 458,060 | +6.8% | 0.00% | 0.0% |
| Q4 2016 | $34,015,000 | +15.5% | 428,721 | +1.9% | 0.00% | 0.0% |
| Q3 2016 | $29,446,000 | +109.3% | 420,661 | +16.0% | 0.00% | +100.0% |
| Q2 2016 | $14,066,000 | -1.2% | 362,609 | +3.1% | 0.00% | 0.0% |
| Q1 2016 | $14,242,000 | -55.2% | 351,676 | -2.0% | 0.00% | -50.0% |
| Q4 2015 | $31,803,000 | -89.8% | 358,673 | -95.3% | 0.00% | -83.3% |
| Q3 2015 | $311,540,000 | +1121.6% | 7,711,488 | +2345.0% | 0.01% | +500.0% |
| Q2 2015 | $25,503,000 | +200.7% | 315,397 | +55.8% | 0.00% | +100.0% |
| Q1 2015 | $8,481,000 | +1464.8% | 202,455 | +479.4% | 0.00% | – |
| Q4 2014 | $542,000 | +29.0% | 34,942 | +5.1% | 0.00% | – |
| Q3 2014 | $420,000 | +138.6% | 33,232 | +171.2% | 0.00% | – |
| Q2 2014 | $176,000 | – | 12,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |